EORTC/MSG definitions

More documents

Recommendations

Info

Definitions - Mycology Culture of mould from tissue. aspirate BAL or sputum antigen in blood, BAL, CSF mould seen in sinus aspirate Mycology Fungi seen in tissue or sterile body fluids 2002
Definitions - Mycology Culture of mould from tissue. aspirate BAL or sputum antigen in blood, BAL, CSF mould seen in sinus aspirate Mycology Beta-D-glucan in BAL, CSF or blood Fungi seen in tissue or sterile body fluids 2007
Page 1 and 2:
Update: New EORTC /MSG criteria for
Page 3 and 4:
EORTC-IFICG & NIAID-MSG 2002
Page 5 and 6:
Strengths
Page 7 and 8:
How valuable do you consider the EO
Page 9 and 10:
Strengths EORTC/MSG definitions •
Page 11 and 12:
• Why revise? • The process •
Page 13 and 14: Problems INAPPROPRIATE USE • appl
Page 15 and 16: Patient groups at risk of developin
Page 17 and 18: Goal of adapting definitions proven
Page 19 and 20: Answer Host factor neutropenic + Cl
Page 21 and 22: ICAAC 43 Chicago 2003 a) the need f
Page 23 and 24: ICAAC 43 Chicago 2003 - working par
Page 25 and 26: QuickTime and a TIFF (Uncompressed)
Page 27 and 28: Plan B Microbiological Criteria.doc
Page 29 and 30: Round 1 E-mail E-mail E-mail E-mail
Page 31 and 32: Definitions II process Round 1 Roun
Page 33 and 34: QuickTime and a TIFF (Uncompressed)
Page 35 and 36: No change
Page 37 and 38: Defining invasive fungal disease Ho
Page 39 and 40: First change
Page 41 and 42: What’s in a name? Invasive Fungal
Page 43 and 44: Definitions I - Possible invasive f
Page 45 and 46: Invasive fungal disease - Definitio
Page 47 and 48: Definitions II - Possible invasive
Page 49 and 50: Definitions - Host factors neutrope
Page 51 and 52: Definitions - Host factors neutrope
Page 53 and 54: Patients at risk of developing IFD
Page 55 and 56: Fourth change
Page 57 and 58: Definitions - Clinical features Low
Page 59 and 60: Definitions - Clinical features Low
Page 61 and 62: Specific pulmonary infiltrates on C
Page 63: Fifth change
Page 67 and 68: Definitions - Mycology Culture of m
Page 69 and 70: Slicing the cake
Page 71 and 72: Separating the chaff from the wheat
Page 73 and 74: Separating the chaff from the wheat
Page 75 and 76: Do you apply EORTC/MSG definitions
Page 77 and 78: Scheme for managing high-risk patie
Page 83 and 84: EORTC/MSG definitions - aspergillos
Page 85 and 86: For example.. CID 2007:44 (15 May)
Page 87 and 88: Table 2. Favorable overall response
Page 89 and 90: At risk population proven probable
Page 91 and 92: Eligible for future studies proven
show all

EORTC/MSG definitions

Create successful ePaper yourself

Delete template?

Save as template?